CCR4 and asthma: Intriguingly, in our study, ZKPC was found to be able to resist the supernatant of M2-induced decrease in cell viability and apoptosis, and reduce the levels of chemokine receptors, CCR3, and CCR4, which are involved in lung inflammation in asthma [36,37].